ABO-21009

N/A

Report date: 2025/05/09 15:54:00

Base Information

Drug NameABO-21009
Drug Alias NameABO-21009
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Protein tyrosine phosphatase receptor type C - isoform C sensitizers
TargetsProtein tyrosine phosphatase receptor type C - isoform C
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbolerIS Pharma SAS
China Registration ClassN/A

Develop Information

Active CompaniesAbolerIS Pharma SAS
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A